• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压患者中肌炎特异性抗体和相关抗体的高患病率。

High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.

作者信息

Tobal Rachid, Potjewijd Judith, van Doorn Daan, van Empel Vanessa, Damoiseaux Jan, van Paassen Pieter

机构信息

Department of Internal Medicine, Division of Nephrology and Clinical and Experimental Immunology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.

Department of Cardiology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.

出版信息

Diagnostics (Basel). 2024 Jul 9;14(14):1471. doi: 10.3390/diagnostics14141471.

DOI:10.3390/diagnostics14141471
PMID:39061608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11276054/
Abstract

Pulmonary hypertension (PH) is a serious condition linked to immune-system dysfunction. Myositis-specific/associated antibodies (MSAs/MAAs) play a role in idiopathic inflammatory myopathy (IIM) and interstitial lung disease (ILD), but their significance in PH remains unclear. We believe the presence of these antibodies may be underestimated. This study analyzed adult PH patients without pre-existing IIM for MSA/MAA prevalence using a line-blot assay. We compared PH patients with and without ILD signs to a cohort clinically suspected of IIM/ILD ( = 558). Our PH cohort ( = 121) showed a significantly higher prevalence of overall weak positive MSAs/MAAs and positive overlap syndrome-associated MAAs than the suspected IIM/ILD group ( < 0.001). Notably, MSAs/MAAs were found in PH patients both with and without ILD, though more prevalent in those with ILD. Anti-synthetase and anti-overlap syndrome antibodies were the most common. Our study is the first to systematically show a high MSA/MAA prevalence in PH without IIM presentation. This highlights the need to consider PH when diagnosing MSA/MAA-associated conditions. We recommend MSA/MAA screening for newly diagnosed PH, especially in those with ILD, for early detection and potential immunomodulatory treatment. Further research should explore the link between MSAs/MAAs and PH, and the value of monitoring patients with weak MSA/MAA positivity over time.

摘要

肺动脉高压(PH)是一种与免疫系统功能障碍相关的严重疾病。肌炎特异性/相关抗体(MSAs/MAAs)在特发性炎性肌病(IIM)和间质性肺疾病(ILD)中起作用,但其在PH中的意义仍不清楚。我们认为这些抗体的存在可能被低估了。本研究使用线性免疫印迹法分析了无既往IIM的成年PH患者中MSA/MAA的患病率。我们将有和无ILD体征的PH患者与临床怀疑患有IIM/ILD的队列(n = 558)进行了比较。我们的PH队列(n = 121)显示,总体弱阳性MSAs/MAAs和阳性重叠综合征相关MAAs的患病率显著高于疑似IIM/ILD组(P < 0.001)。值得注意的是,在有和无ILD的PH患者中均发现了MSAs/MAAs,尽管在有ILD的患者中更为普遍。抗合成酶抗体和抗重叠综合征抗体最为常见。我们的研究首次系统地显示了无IIM表现的PH患者中MSA/MAA的高患病率。这突出了在诊断与MSA/MAA相关疾病时考虑PH的必要性。我们建议对新诊断的PH患者进行MSA/MAA筛查,尤其是对那些有ILD的患者,以便早期发现并进行潜在的免疫调节治疗。进一步的研究应探索MSAs/MAAs与PH之间的联系,以及长期监测MSA/MAA弱阳性患者的价值。

相似文献

1
High Prevalence of Myositis-Specific and Associated Antibodies in Patients with Pulmonary Hypertension.肺动脉高压患者中肌炎特异性抗体和相关抗体的高患病率。
Diagnostics (Basel). 2024 Jul 9;14(14):1471. doi: 10.3390/diagnostics14141471.
2
Myositis-specific and myositis-associated autoantibodies in a large Indian cohort of inflammatory myositis.在一个大型印度炎症性肌炎队列中肌炎特异性和肌炎相关性自身抗体。
Semin Arthritis Rheum. 2021 Feb;51(1):113-120. doi: 10.1016/j.semarthrit.2020.10.014. Epub 2020 Dec 22.
3
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies.一种评估间质性肺疾病中肌痛的新方法:与肌炎特异性抗体和肌炎相关抗体阳性的关联
Diagnostics (Basel). 2022 May 4;12(5):1139. doi: 10.3390/diagnostics12051139.
4
Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype.肌炎特异性抗体可识别一种具有自身免疫特征表型的独特间质性肺炎。
Eur Respir J. 2020 Dec 3;56(6). doi: 10.1183/13993003.01205-2020. Print 2020 Dec.
5
Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.希腊炎性肌病患者的自身抗体谱及其与临床的关联。
Clin Rheumatol. 2019 Jan;38(1):125-132. doi: 10.1007/s10067-018-4267-z. Epub 2018 Aug 25.
6
Line blot immunoassays in idiopathic inflammatory myopathies: retrospective review of diagnostic accuracy and factors predicting true positive results.特发性炎性肌病的线性印迹免疫分析:诊断准确性及预测真阳性结果因素的回顾性研究
BMC Rheumatol. 2020 Jul 20;4:28. doi: 10.1186/s41927-020-00132-9. eCollection 2020.
7
[Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].[肌炎抗体在结缔组织病相关间质性肺疾病患者中的临床价值]
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Oct 12;42(10):765-770. doi: 10.3760/cma.j.issn.1001-0939.2019.10.010.
8
Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.特发性炎性肌病成人患者的肌炎特异性自身抗体:与诊断及疾病活动度的相关性
Clin Rheumatol. 2021 Mar;40(3):1009-1016. doi: 10.1007/s10067-020-05273-3. Epub 2020 Jul 16.
9
Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.皮肌炎中无肌炎特异性和肌炎相关自身抗体相关的间质性肺病:来自单一队列的 72 例患者系列研究。
Front Immunol. 2022 May 6;13:879266. doi: 10.3389/fimmu.2022.879266. eCollection 2022.
10
Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.特发性炎性肌病:间质性肺疾病的CT特征及其与肌炎特异性自身抗体的关联
Eur Radiol. 2022 May;32(5):3480-3489. doi: 10.1007/s00330-021-08411-w. Epub 2022 Jan 13.

引用本文的文献

1
Dephosphorylated uncarboxylated Matrix-Gla-Protein as candidate biomarker for immune-mediated vascular remodeling and prognosis in pulmonary hypertension.去磷酸化未羧化基质 Gla 蛋白作为免疫介导的血管重构和肺动脉高压预后的候选生物标志物。
Sci Rep. 2024 Nov 4;14(1):26633. doi: 10.1038/s41598-024-77000-w.

本文引用的文献

1
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.与结缔组织病相关的肺动脉高压(CTD-PAH):最新和进展数据。
Autoimmun Rev. 2024 Apr;23(4):103506. doi: 10.1016/j.autrev.2023.103506. Epub 2023 Dec 21.
2
Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.在一大群确诊的特发性炎性肌病患者的多中心队列中,通过多分析免疫测定法检测肌炎自身抗体。
Diagnostics (Basel). 2023 Sep 28;13(19):3080. doi: 10.3390/diagnostics13193080.
3
The vascular perspective on acute and chronic lung disease.
从血管角度看急性和慢性肺病。
J Clin Invest. 2023 Aug 15;133(16):e170502. doi: 10.1172/JCI170502.
4
The PH-ILD Detection tool: External validation and use in patients with ILD.PH-ILD检测工具:外部验证及在ILD患者中的应用
Pulm Circ. 2023 Aug 8;13(3):e12273. doi: 10.1002/pul2.12273. eCollection 2023 Jul.
5
The endothelium in lung fibrosis: a core signaling hub in disease pathogenesis?肺纤维化中的内皮细胞:疾病发病机制中的核心信号枢纽?
Am J Physiol Cell Physiol. 2023 Jul 1;325(1):C2-C16. doi: 10.1152/ajpcell.00097.2023. Epub 2023 May 15.
6
[2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].[2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南]
G Ital Cardiol (Rome). 2023 Apr;24(4 Suppl 1):e1-e116. doi: 10.1714/4014.39906.
7
Systemic Lupus Erythematosus and Pulmonary Hypertension.系统性红斑狼疮与肺动脉高压。
Int J Mol Sci. 2023 Mar 7;24(6):5085. doi: 10.3390/ijms24065085.
8
Inflammatory biomarkers in pulmonary arterial hypertension: ready for clinical implementation?肺动脉高压中的炎症生物标志物:准备好用于临床实践了吗?
Eur Respir J. 2023 Mar 23;61(3). doi: 10.1183/13993003.00018-2023. Print 2023 Mar.
9
Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.血管-实质相互作用通过 BMPR2 信号促进肺纤维化。
Am J Respir Crit Care Med. 2023 Jun 1;207(11):1498-1514. doi: 10.1164/rccm.202109-2174OC.
10
Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need.间质性肺疾病中的肺动脉高压:一个尚未满足的临床需求领域。
ERJ Open Res. 2022 Nov 14;8(4). doi: 10.1183/23120541.00272-2022. eCollection 2022 Oct.